Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden
Clinical Infectious Diseases · 15.05.2024 · 78 (5) · 1222-1231
DOI: 10.1093/cid/ciae098 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 23.02.2024. Verfasst von Martin Plymoth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Sunderby Research Unit, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Tularemia, Anti-Bacterial Agents, Doxycycline. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: County Council of Norrbotten, Umeå University, Region Västerbotten.
Abstract (Originalsprache)
Background
Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment outcomes of laboratory-confirmed tularemia cases over an 11-year period in Northern Sweden.
Methods
Data from reported tularemia cases (aged >10 years at time of study) in Norrbotten county between 2011 and 2021 were collected through review of electronic medical records and participant questionnaires; 415 of 784 accepted participation (52.9%). Of these, 327 were laboratory-confirmed cases (serology and/or polymerase chain reaction). A multivariable logistic regression model was used to investigate variables associated with retreatment.
Results
Median age of participants was 54 years (interquartile range [IQR], 41.5–65) and 49.2% were female. Although ulceroglandular tularemia was the predominant form (n = 215, 65.7%), there were several cases of pulmonary tularemia (n = 40; 12.2%). Inflammatory markers were largely nonspecific, with monocytosis frequently observed (n = 36/75; 48%). Tularemia was often misdiagnosed on presentation (n = 158, 48.3%), with 65 (19.9%) receiving initial inappropriate antibiotics and 102 (31.2%) retreated. Persistent lymphadenopathy was infrequent (n = 22, 6.7%), with 10 undergoing surgical interventions. In multivariable analysis of variables associated with retreatment, we highlight differences in time until receiving appropriate antibiotics (8 [IQR, 3.25–20.75] vs 7 [IQR, 4–11.25] days; adjusted P = .076), and doxycycline-based treatment regimen (vs ciprofloxacin; adjusted P = .084), although this was not significant after correction for multiple comparisons.
Conclusions
We comprehensively summarize clinical, laboratory, and treatment outcomes of type B tularemia. Targeting tularemia requires clinical awareness, early diagnosis, and timely commencement of treatment for an appropriate duration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Sunderby Research Unit, Umeå University, Umeå, Sweden.
- Department of Infectious Diseases, Westmead Hospital, Sydney, New South Wales, Australia.
- Department of Public Health and Clinical Medicine, Sunderby Research Unit, Umeå University, Umeå, Sweden.
- Department of Communicable Disease Control, County Council of Norrbotten, Luleå, Sweden.
- Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
ORCID-Profile: Martin Plymoth, Robert Lundqvist, Anders Sjöstedt, Tomas N Gustafsson
Förderung
- County Council of Norrbotten
- Umeå University
- Region Västerbotten
Zitieren
APA
Plymoth, M., Lundqvist, R., Nystedt, A., Sjöstedt, A., & Gustafsson, T. N. (2024). Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden. Clinical Infectious Diseases, 78(5), 1222-1231. https://doi.org/10.1093/cid/ciae098
Vancouver
Plymoth M, Lundqvist R, Nystedt A, Sjöstedt A, Gustafsson TN. Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden. Clinical Infectious Diseases. 2024;78(5):1222-1231. doi:10.1093/cid/ciae098
BibTeX
@article{Plymoth2024,
author = {Plymoth, Martin and Lundqvist, Robert and Nystedt, Anders and Sjöstedt, Anders and Gustafsson, Tomas N},
title = {Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {5},
pages = {1222--1231},
doi = {10.1093/cid/ciae098}
}
EUVIMED